Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.
Foreign Product Alert: Plexus Slim Accelerator capsules, and Plexus Slim Accelerator 3 Day Trial pack
- Starting date:
- February 7, 2014
- Posting date:
- February 7, 2014
- Type of communication:
- Foreign Product Alert (FPA)
- Natural health products
- Source of recall:
- Health Canada
- Source of alert:
Australia Therapeutic Goods Administration
- Undeclared Substance
- General Public
- Identification number:
These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.
- Plexus Slim Accelerator capsules
- Plexus Slim Accelerator 3 Day Trial pack
Plexus Slim Accelerator capsules, and Plexus Slim Accelerator 3 Day Trial pack
These products are promoted for weight loss.
The Australia Therapeutic Goods Administration (TGA) warned consumers not to use these products as they were found to contain 1,3-dimethylamylamine (DMAA), a drug that is not approved for sale in Canada.
Health Canada received one Canadian report of a serious adverse reaction suspected to be associated with a "Plexus Slim Accelerator" product. Due to limited information at this time, Health Canada is unable to determine whether the product reported is the same as the product that is the subject of the TGA alert, or what role, if any, the product may have played in the adverse reaction. It is not known where the product was purchased. Health Canada is currently following up on this report.
Place of origin
Side effects associated with DMAA include high blood pressure, shortness of breath, chest pain, stroke and psychiatric disorders.
What you should do
Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find either of the products listed above in the Canadian marketplace.
Canadians who have these products are advised not to use them, and should consult with a health care professional if they have concerns about their health related to the use of these products.
Drugs and natural health products that are authorized for sale in Canada will have an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.
As of December 31, 2013, Health Canada has received one report of an adverse reaction suspected to be associated with the use of these products.
Report a health of safety concern
To report a side effect to a health product to Health Canada:
- Call toll-free at 1-866-234-2345
- Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax
Select thumbnail to enlarge - opens in a new window
- Date modified: